Endogenous <i>S</i> -nitrosothiols protect against myocardial injury

Brian Lima, Gregory K.W. Lam, Liang Xie, Diana L. Diesen, Nestor Villamizar, Jeffrey J. Nienaber, Emily Messina, Dawn E. Bowles, Christopher D. Kontos, Joshua M. Hare,

Proceedings of the National Academy of Sciences · 2009 · 223 citations · 28 references

DOIFull text

Open access

Concepts

Abstract

Despite substantial evidence that nitric oxide (NO) and/or endogenous S-nitrosothiols (SNOs) exert protective effects in a variety of cardiovascular diseases, the molecular details are largely unknown. Here we show that following left coronary artery ligation, mice with a targeted deletion of the S-nitrosoglutathione reductase gene (GSNOR(-/-)) have reduced myocardial infarct size, preserved ventricular systolic and diastolic function, and maintained tissue oxygenation. These profound physiological effects are associated with increases in myocardial capillary density and S-nitrosylation of the transcription factor hypoxia inducible factor-1alpha (HIF-1alpha) under normoxic conditions. We further show that S-nitrosylated HIF-1alpha binds to the vascular endothelial growth factor (VEGF) gene, thus identifying a role for GSNO in angiogenesis and myocardial protection. These results suggest innovative approaches to modulate angiogenesis and preserve cardiac function.

References

28